Essentials of Thyroid Cancer Management pp 267-279 | Cite as
Potential Side Effects and Complications of I-131 Therapy
Chapter
Keywords
Salivary Gland Differentiate Thyroid Cancer Bone Marrow Suppression Thyroid Remnant Total Cumulative Dose
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- Ceccarelli, C, W Bencivelli, D Morciano, A Pinchera, and F Pacini. 2001. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. J Clin Endocrinol Metab 86(8):3512–3515.CrossRefPubMedGoogle Scholar
- Chow, S, S Yau, S Lee, W Leung, and SC Law. 2004. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment. Int J Radiat Oncol Biol Phys 59(4):992–1000.CrossRefPubMedGoogle Scholar
- Mandel, SJ, and L Mandel. 2003. Radioactive iodine and the salivary glands. Thyroid 13(3):265–271.CrossRefPubMedGoogle Scholar
- Raymond, JP, M Izembart, V Marliac, F Dagousset, RE Merceron, M Vulpillat, et al. 1989. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab 69:186–190.PubMedGoogle Scholar
- Rubino, C, F de Vathaire, ME Dottorini, P Hall, C Schvartz, JE Couette, MG Dondon, MT Abbas, C Langlois, and M Schlumberger. 2003. Second primary malignancies in thyroid cancer patients. Br J Cancer 89(9):1638–1644.CrossRefPubMedGoogle Scholar
Copyright information
© Springer Science+Business Media, Inc. 2005